Rephyll is a patent-pending innovation that incorporates terpenes from Black Pepper (derived from plants like Piper Nigrum) utilizing our proprietary powdered liposomal delivery platform Zeal Technology. Rephyll acts as a selective binder for the CB2 receptor, the therapeutic target for inflammation. It is also shown to have anti-microbial and anti-oxidant properties.
Powered by Zeal Technology
Black pepper derivatives while rich in benefits has not reached its full market potential due to its limited functionality and stability in a finished product formulations. Rephyll®, leveraging Aurea Biolabs’ proprietary Zeal® Technology overcomes this by protecting the bio-active molecule against degradation and ensuring targeted delivery. Zeal technology has shown to increase bioavailability of a variety of bioactives.